Saba Capital Management, L.P.: Form SC 13D/A - Filed by newsfilecorp.com

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D/A

Under the Securities Exchange Act of 1934 (Amendment No. 3)

First Trust High Income Long/Short Fund
(Name of Issuer)

Common Stock, par value $0.01 per share
(Title of Class of Securities)

33738E109
(CUSIP Number)

Saba Capital Management, L. P.
405 Lexington Avenue
58
th Floor
New York, NY, 10174
Attention: Michael D’Angelo
212-542-4635
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

December 13, 2016
(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d -1(e), 240.13d -1(f) or 240.13d -1(g), check the following box [ X ].

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


SCHEDULE 13D/A

CUSIP No. 33738E109

1      NAMES OF REPORTING PERSONS  
       I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
     
       Saba Capital Management, L.P.  
2      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*  
     
  (a) [   ]  
  (b)

[   ]

 
3      SEC USE ONLY    
         
4      SOURCE OF FUNDS (See Instructions)  
     
       OO (see item 3)  
5      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)  
                                                                                                 [   ]                                
6      CITIZENSHIP OR PLACE OF ORGANIZATION  
     
       Delaware    
NUMBER OF 7      SOLE VOTING POWER  
       
SHARES        -0-  
       
BENEFICIALLY 8      SHARED VOTING POWER  
       
OWNED BY        4,422,377  
       
EACH 9      SOLE DISPOSITIVE POWER  
       
REPORTING        -0-  
       
     PERSON 10      SHARED  DISPOSITIVE POWER  
       
WITH        4,422,377  
11      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
     
       4,422,377    
12      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)  
     

                                                                                     [    ]

         
13      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
     
       12.54%*    
14      TYPE OF REPORTING PERSON (See Instructions)  
     
       PN; IA      

*  The percentages used in this Schedule 13D/A are calculated based upon 35,272,607 Common Shares outstanding as of April 30, 2016 as reported in the Issuer's Semi-Annual Report to Shareholders on Form N-CSRS filed on July 5, 2016.


Page 2

SCHEDULE 13D/A

CUSIP No. 33738E109

1      NAMES OF REPORTING PERSONS  
       I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
       Boaz R. Weinstein  
2      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*  
  (a) [   ]  
  (b)

[   ]

 
3      SEC USE ONLY  
         
4      SOURCE OF FUNDS (See Instructions)  
       OO (see item 3)  
5      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)  
                                               [   ]                                                          
6      CITIZENSHIP OR PLACE OF ORGANIZATION  
       United States  
NUMBER OF 7      SOLE VOTING POWER  
SHARES        -0-  
BENEFICIALLY 8      SHARED VOTING POWER  
OWNED BY        4,422,377  
EACH 9      SOLE DISPOSITIVE POWER  
REPORTING        -0-  
PERSON 10      SHARED DISPOSITIVE POWER  
WITH        4,422,377  
11      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
       4,422,377    
12      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)  

 [   ]

                                                                                                                                                                                                                                                                                                                           
13      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
       12.54%*    
14      TYPE OF REPORTING PERSON (See Instructions)  

 

     IN

 

 

 

* The percentages used in this Schedule 13D/A are calculated based upon 35,272,607 Common Shares outstanding as of April 30, 2016 as reported in the Issuer's Semi-Annual Report to Shareholders on Form N-CSRS filed on July 5, 2016.


Page 3

CUSIP No. 33738E109 SCHEDULE 13D/A  

This Amendment No. 3 (“Amendment No. 3”) amends and supplements the statement on Schedule 13D filed on September 8, 2016 (the “Original Schedule 13D”) and Amendment No. 1 to the Original Schedule 13D, filed with the Securities and Exchange Commission (the "SEC") on October 24, 2016 (“Amendment No. 1”), and Amendment No. 2 filed with the SEC on November 16, 2016 (“Amendment No. 2”). Together with this Amendment No. 3, Amendment No. 2, Amendment No. 1, and the Original Schedule 13D, with respect to the shares of common stock, $0.01 per share (the “Shares”), of First Trust High Income Long/Short Fund (the “Issuer”). Capitalized terms used herein and not otherwise defined in this Amendment No. 3 have the meanings set forth in the Original Schedule 13D, Amendment No. 1, and Amendment No. 2. This Amendment No. 3 amends Items 3 and 5 as set forth below.

Item 3. Source and amount of funds or other consideration

Item 3 of the Schedule 13D is hereby amended and restated as follows:

Funds for the purchase of the Shares were derived from the subscription proceeds from investors in SCMF, SCMF II, SCLMF, SCS, SCEF 1 and SCEF 2 and the capital appreciation thereon and margin account borrowings made in the ordinary course of business. In such instances, the positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in the account, which may exist from time to time. Since other securities are held in the margin accounts, it is not possible to determine the amounts, if any, of margin used to purchase the Shares reported herein. A total of $66,866,659 was paid to acquire the Shares reported herein

Item 5. Interest in Securities of the Issuer

Item 5 of the Schedule 13D/A is hereby amended and restated as follows:

(a)

See rows (11) and (13) of the cover pages to this Schedule 13D/A for the aggregate number of Shares and percentages of the Shares beneficially owned by each of the Reporting Persons. The percentages used in this Schedule 13D/A are calculated based upon 35,272,607 Shares outstanding as of April 30, 2016 as reported in the Issuer's Annual Report to Shareholders on Form N-CSRS filed on July 5, 2016.

   
(b)

See rows (7) through (10) of the cover pages to this Schedule 13D/A for the number of Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.

   
(c)

The transactions in the Shares effected since the filing of the Amendment No. 2 by Saba Capital, which were all in the open market, are set forth in Schedule A, and are incorporated herein by reference.

   
(d)

No person other than the Reporting Persons and the Saba Entities is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, such Shares.

   
(e)

Not applicable.



Page 4

CUSIP No. 33738E109 SCHEDULE 13D/A  

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

12/14/2016
Dated
 
 
 
/s/ Michael D'Angelo
Name: Michael D'Angelo
Title: Chief Compliance Officer
 
 
BOAZ R. WEINSTEIN
/s/ Michael D'Angelo
Name: Michael D'Angelo
Title: Attorney-in-fact*
 
 
 

* Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823



Page 5

CUSIP No. 33738E109 SCHEDULE 13D/A  

Schedule A

This Schedule sets forth information with respect to each purchase and sale of Shares which were effectuated by a Reporting Person since the Schedule 13D/A Amendment No. 2 filing on 11/14/2016. All transactions were effectuated in the open market through a broker.

SABA CAPITAL MANAGEMENT, L.P ("Saba Capital")

    Shares        
Trade Date   Purchased     Price*  
12/13/2016   57,607     15.96  
12/13/2016   73,582     15.99  
12/12/2016   26,220     15.88  
12/9/2016   9,572     15.85  
12/8/2016   43,805     15.80  
12/7/2016   60,806     15.66  
12/6/2016   36,128     15.55  
12/5/2016   12,550     15.50  
11/28/2016   2,898     15.64  
11/18/2016   19,528     15.38  
11/16/2016   37,331     15.38  
11/15/2016   37,930     15.25  
11/14/2016   38,899     15.07  

*Excluding commissions